Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila.
about
Drosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular DiseasesA brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases.A peptidylic inhibitor for neutralizing expanded CAG RNA-induced nucleolar stress in polyglutamine diseases.
P2860
Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Assessing a peptidylic inhibit ...... patient cells and Drosophila.
@en
type
label
Assessing a peptidylic inhibit ...... patient cells and Drosophila.
@en
prefLabel
Assessing a peptidylic inhibit ...... patient cells and Drosophila.
@en
P2093
P2860
P50
P356
P1476
Assessing a peptidylic inhibit ...... patient cells and Drosophila.
@en
P2093
Dobrila D Rudnicki
Qian Zhang
Shaohong Peng
P2860
P304
P356
10.1242/DMM.022350
P577
2016-02-02T00:00:00Z